Literature DB >> 23188513

Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis.

Atsushi Watanabe1, Masayoshi Miyajima, Taijiro Mishina, Junji Nakazawa, Ryo Harada, Nobuyoshi Kawaharada, Tetsuya Higami.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. IPF is associated with an increased risk of lung cancer, and lung cancer patients with IPF undergoing pulmonary resection for non-small cell lung cancer have increased postoperative morbidity and mortality. Especially, postoperative acute exacerbation of IPF (AEIPF) causes fatal status and long-term outcomes are worse than for patients without IPF, although certain subgroups have a good long-term outcome. A comprehensive review of the current literature pertaining to AEIPF and the late phase outcome after the context of a surgical intervention was performed.

Entities:  

Mesh:

Year:  2012        PMID: 23188513     DOI: 10.1007/s11748-012-0180-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  60 in total

1.  Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Fahad M Al-Hameed; Sat Sharma
Journal:  Can Respir J       Date:  2004-03       Impact factor: 2.409

2.  Cumulative incidence of and predictive factors for lung cancer in IPF.

Authors:  Yuichi Ozawa; Takafumi Suda; Tateaki Naito; Noriyuki Enomoto; Dai Hashimoto; Tomoyuki Fujisawa; Yutaro Nakamura; Naoki Inui; Hirotoshi Nakamura; Kingo Chida
Journal:  Respirology       Date:  2009-07       Impact factor: 6.424

3.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Derek Weycker; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Lisa Lancaster; Paul W Noble; Ganesh Raghu; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

4.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

5.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure.

Authors:  J B Stern; H Mal; O Groussard; O Brugière; A Marceau; G Jebrak; M Fournier
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 6.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Susumu Sakamoto; Sakae Homma; Atsushi Miyamoto; Atsuko Kurosaki; Takeshi Fujii; Kunihiko Yoshimura
Journal:  Intern Med       Date:  2010-01-15       Impact factor: 1.271

8.  Risk factors for acute lung injury after thoracic surgery for lung cancer.

Authors:  Marc Licker; Marc de Perrot; Anastase Spiliopoulos; John Robert; John Diaper; Catherine Chevalley; Jean-Marie Tschopp
Journal:  Anesth Analg       Date:  2003-12       Impact factor: 5.108

9.  [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].

Authors:  Mari Nakamura; Takashi Ogura; Naoki Miyazawa; Akihiro Tagawa; Satoko Kozawa; Yuji Watanuki; Hiroshi Takahashi
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2007-06

10.  Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia.

Authors:  Noriyuki Enomoto; Takafumi Suda; Tomohiro Uto; Masato Kato; Yusuke Kaida; Yuichi Ozawa; Hiroo Miyazaki; Shigeki Kuroishi; Dai Hashimoto; Tateaki Naito; Tomoyuki Fujisawa; Takashi Matsui; Naoki Inui; Yutaro Nakamura; June Sato; Tomoaki Mizuguchi; Akihiko Kato; Kingo Chida
Journal:  Respirology       Date:  2008-05       Impact factor: 6.424

View more
  14 in total

1.  Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis.

Authors:  Seok Joo; Dong Kwan Kim; Hee Je Sim; Geun Dong Lee; Su Kyung Hwang; Sehoon Choi; Hyeong Ryul Kim; Yong-Hee Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  [Cardiac surgery in underlying chronic pulmonary disease. Prognostic implications and efficient preoperative evaluation].

Authors:  D Fistera; H Steveling; A Koch; H Teschler
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 3.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis.

Authors:  Masatoshi Kanayama; Masataka Mori; Hiroki Matsumiya; Akihiro Taira; Shinji Shinohara; Taiji Kuwata; Naoko Imanishi; Kazue Yoneda; Koji Kuroda; Fumihiro Tanaka
Journal:  Surg Today       Date:  2019-11-26       Impact factor: 2.549

5.  What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

Authors:  Masahiro Miyajima; Atsushi Watanabe; Toshihiko Sato; Satoshi Teramukai; Masahito Ebina; Kazuma Kishi; Yukihiko Sugiyama; Haruhiko Kondo; Satoru Kobayashi; Yutaka Takahashi; Hiroyuki Ito; Ryoji Yamamoto; Shigeki Sawada; Hideki Fujimori; Kazunori Okabe; Jun Arikura; Yasushi Shintani; Hiroshige Nakamura; Shinichi Toyooka; Tohru Hasumi; Takehiro Watanabe; Yoshinobu Hata; Hisashi Iwata; Minoru Aoki; Kazuhito Funai; Shuhei Inoue; Osamu Kawashima; Tomohiko Iida; Hiroshi Date
Journal:  Surg Today       Date:  2017-11-09       Impact factor: 2.549

6.  A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients.

Authors:  Toshihiko Sato; Haruhiko Kondo; Atsushi Watanabe; Jun Nakajima; Hiroshi Niwa; Hirotoshi Horio; Jiro Okami; Norihito Okumura; Kenji Sugio; Satoshi Teramukai; Kazuma Kishi; Masahito Ebina; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-10-30

7.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.

Authors:  Takekazu Iwata; Shigetoshi Yoshida; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Tetsuzo Tagawa; Teruaki Mizobuchi; Satoshi Ota; Yukio Nakatani; Ichiro Yoshino
Journal:  Surg Today       Date:  2014-11-22       Impact factor: 2.549

8.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

Review 9.  Molecular mechanisms in male determination and germ cell differentiation.

Authors:  L Ronfani; M E Bianchi
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

10.  A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).

Authors:  Takekazu Iwata; Ichiro Yoshino; Shigetoshi Yoshida; Norihiko Ikeda; Masahiro Tsuboi; Yuji Asato; Nobuyuki Katakami; Kazuhiro Sakamoto; Yoshinori Yamashita; Jiro Okami; Tetsuya Mitsudomi; Motohiro Yamashita; Hiroshi Yokouchi; Kenichi Okubo; Morihito Okada; Mitsuhiro Takenoyama; Masayuki Chida; Keisuke Tomii; Motoki Matsuura; Arata Azuma; Tae Iwasawa; Kazuyoshi Kuwano; Shuji Sakai; Kenzo Hiroshima; Junya Fukuoka; Kenichi Yoshimura; Hirohito Tada; Kazuhiko Nakagawa; Yoichi Nakanishi
Journal:  Respir Res       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.